mda mb 453 (ATCC)
Structured Review

Mda Mb 453, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 2063 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mda mb 453/product/ATCC
Average 98 stars, based on 2063 article reviews
Images
1) Product Images from "Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2-positive breast cancer"
Article Title: Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2-positive breast cancer
Journal: International Journal of Molecular Medicine
doi: 10.3892/ijmm.2026.5751
Figure Legend Snippet: EBA induces apoptosis in trastuzumab-resistant breast cancer cells. (A) Chemical structure of EBA. (B) Cell viability and IC 50 values were determined using the MTS assay. JIMT-1 and MDA-MB-453 cells were treated with EBA (48 h) and analyzed by flow cytometry to assess (C) sub-G1 phase populations and (D) early and late apoptotic cells. (E) Morphological changes in JIMT-1 cells following EBA treatment, observed by phase-contrast microscopy. Magnification, x200. (F) Effect of EBA on the expression of PARP, cleaved PARP, caspase-3, -7 and -8 and cleaved caspase-3, -7 and -8 in JIMT-1 cells. GAPDH was used as a loading control. * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001 vs. vehicle-treated control (0 μ M EBA). EBA, ebastine.
Techniques Used: MTS Assay, Flow Cytometry, Microscopy, Expressing, Control